Clovis Oncology (NASDAQ:CLVS) announced that five abstracts highlighting clinical progress and results from Phase 1 and 2 studies of the company’s three compounds will be presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Help employers find you! Check out all the jobs and post your resume.
